Adare Pharmaceuticals, Inc.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 845 Center Dr., Vandalia, Ohio (OH) 45377-3129, United States (USA)
- Operations here
- analysisapi manufacturemanufacturepack
- FDA identifiers
- FEI 1525864 · DUNS 079819927
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2025-02-25
- NAIDrug Quality Assurance2019-01-25
- NAIBioresearch Monitoring2018-07-11
- NAIDrug Quality Assurance2017-05-19
- NAIDrug Quality Assurance2012-11-16
- VAIDrug Quality Assurance2011-12-21
- NAIDrug Quality Assurance2011-06-17
- NAIDrug Quality Assurance2009-11-20
Drugs this plant is listed as making
5 distinct drugs across 14 products name this site in their FDA label.
- Cyclobenzaprine HydrochlorideAmneal Pharmaceuticals of New York LLC
- FenofibrateRhodes Pharmaceuticals LLC
- Potassium ChlorideAdare Pharmaceuticals Inc
- propranolol hydrochloridein shortageBreckenridge Pharmaceutical, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.